BW
INTS icon

Bison Wealth’s Intensity Therapeutics INTS Stock Holding History

Bison Wealth’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$30.7K Hold
697
– – 0.01% 317
2024
Q3 		$66.5K Hold
697
– – 0.01% 411
2024
Q2 		$90.6K Hold
697
– – 0.01% 408
2024
Q1 		$90.6K Buy
+697
New +$83.5K 0.01% 410

Other funds holding INTS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Bison Wealth's INTS Position: Q4 2024 in Review

Bison Wealth held its Intensity Therapeutics (INTS) position steady in Q4 2024 at 697 shares worth $30.7K. The position accounts for 0.01% of the portfolio, ranked #317.

Bison Wealth first reported a position in INTS in Q1 2024 and has held it in 4 quarters since. The position peaked at $90.6K in Q2 2024. 20 funds tracked by Wall St. Rank hold INTS as of Q4 2024.

  • Bison Wealth held 697 shares of Intensity Therapeutics worth $30.7K as of Q4 2024.
  • Bison Wealth left its Intensity Therapeutics share count unchanged in Q4 2024.
  • Intensity Therapeutics made up 0.01% of Bison Wealth's portfolio in Q4 2024, its #317 holding.
  • Bison Wealth first reported a position in Intensity Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Bison Wealth's Intensity Therapeutics position peaked at $90.6K in Q2 2024.
  • 20 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q4 2024.

Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.